Combined BCL2 and BTK inhibition in CLL demonstrates efficacy after monotherapy with both classes
Titel:
Combined BCL2 and BTK inhibition in CLL demonstrates efficacy after monotherapy with both classes
Auteur:
Hyak, Jonathan M. Huang, Ying Rogers, Kerry A. Bhat, Seema A. Grever, Michael R. Byrd, John C. Kittai, Adam S. Jones, Dan Miller, Cecelia R. Woyach, Jennifer A.